RxDoctor Payments Data

Briana Goodridge, APRN

Nurse Practitioner · Crestview Hills, KYNPI 1942796206

Payments from drug & device makers

$2,056in general payments, 2019–2025

Across 111 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$473
  • Takeda Pharmaceuticals U.S.A., Inc.$214
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$207
  • QOL Medical, LLC$192
  • Lilly USA, LLC$140
  • Daiichi Sankyo Inc.$137
  • plus $694 from 18 others

What the payments were for

  • Food & beverage$2,056100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,056 in reported general payments places this provider in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$24,799
Medicare patients
250
Services billed
291

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide67$52,780
XifaxanRifaximin13$32,332
MovantikNaloxegol Oxalate14$5,418
Dexlansoprazole DrDexlansoprazole16$4,751
Misoprostol37$3,741
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C23$3,216
Pantoprazole Sodium285$2,735
Budesonide DrBudesonide17$2,637
Omeprazole246$2,449
Colestipol Hcl38$2,437
Dicyclomine Hcl110$2,144
Ondansetron OdtOndansetron81$1,662
Lansoprazole11$1,376
Esomeprazole Magnesium50$1,351
Sucralfate25$1,268

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$473$52,78067 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Plenvu$207$35,54836 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Crestview Hills

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →